GRPR-targeted Theranostics for Cancer Management: New approaches to maximize therapeutic success [PDF]
In nuclear medicine, molecular imaging utilizing tumor-targeting radioactive agents can be used to non-invasively identify cancer patients eligible for targeted radionuclide therapy based on a positive scan, a concept known as theranostics.
Verhoeven, Marjolein
core
Pretargeted Immuno-PET Enables Monoclonal Antibody Imaging Beyond the Blood-Brain Barrier. [PDF]
Gustavsson T +17 more
europepmc +1 more source
GPA33-pretargeted radioimmunotherapy with mono- and bivalent DOTA-based Lu-177-labeled radiohaptens in a mouse orthotopic liver xenograft model of metastatic human colorectal cancer. [PDF]
Le Roux AB +13 more
europepmc +1 more source
Pretargeting with Cucurbituril-Adamantane Host-Guest Pair in Xenograft Models. [PDF]
Jallinoja VIJ +7 more
europepmc +1 more source
Emerging therapeutics for the treatment of light chain and transthyretin amyloidosis [PDF]
Lenihan, Daniel J +2 more
core +1 more source
Through every lens: assessing the impact of chemical modifications on antibody-conjugates using in vivo imaging. [PDF]
Edupuganti VVSR +2 more
europepmc +1 more source
Toward Realization of Bioorthogonal Chemistry in the Clinic. [PDF]
de Roode KE, Rossin R, Robillard MS.
europepmc +1 more source
Recent advances in multimodal imaging of infections: research highlights using Nuclear-Optical imaging. [PDF]
Welling MM +4 more
europepmc +1 more source
Click-to-Release for Controlled Immune Cell Activation: Tumor-Targeted Unmasking of an IL12 Prodrug. [PDF]
den Brok MH +8 more
europepmc +1 more source
Alpha Particle Emitter Radiolabeled Antibodies in Cancer Therapy: Current Status, Challenges, and Future Prospects. [PDF]
Palangka CRAP +4 more
europepmc +1 more source

